INDP · Indaptus Therapeutics, Inc. · Documents
$3.00
+0.04 (+1.35%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$394.40M
Shares
133.24M
Volume · Oct 20
218.73K
Avg daily vol (3M)
875.19K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3 | — | 2022-09-01 | — | |
| 10-Q | — | 2022-08-08 | 2022-06-30 | |
| 8-K | — | 2022-08-08 | — | |
| DEFA14A | — | 2022-08-04 | — | |
| DEF 14A | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-21 | 2022-07-20 | |
| S-3 | — | 2022-06-01 | — | |
| 8-K | — | 2022-06-01 | — | |
| 8-K | — | 2022-05-19 | — | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 8-K | — | 2022-03-21 | — | |
| 10-K | — | 2022-03-21 | 2021-12-31 | |
| 8-K | — | 2022-02-01 | — | |
| 8-K | — | 2022-01-03 | — | |
| 8-K | — | 2021-12-02 | 2021-11-29 | |
| 8-K | — | 2021-11-15 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| S-1 | — | 2021-09-24 | — | |
| S-3 | — | 2021-08-16 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-08-16 | — | |
| 8-K/A | — | 2021-08-16 | 2021-08-12 | |
| 8-K | — | 2021-08-06 | 2021-08-03 | |
| 8-K | — | 2021-08-06 | 2021-08-03 | |
| 8-K | — | 2021-07-29 | 2021-07-23 | |
| 8-K | — | 2021-07-23 | — | |
| 8-K | — | 2021-07-16 | 2021-07-13 | |
| 10-Q | — | 2021-06-28 | 2021-03-31 | |
| 8-K | — | 2021-06-22 | 2021-06-21 | |
| S-4/A | — | 2021-05-12 | — | |
| S-4 | — | 2021-04-20 | — |
Showing 101–132 of 132 filings